2023 annual financial data
Solid Biosciences 2023 Operating margin
Solid Biosciences 2023 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -104,315,000 USD and net income was -96,015,000 USD.
Operating cash flow was -94,180,000 USD.
Get free Solid Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -104,315,000 USD
- Net income
- -96,015,000 USD
- Operating cash flow
- -94,180,000 USD